Literature DB >> 278588

Pituitary control of ovarian function--concepts derived from gonadotrophin therapy.

J B Brown.   

Abstract

From experience gained in the monitoring of ovarian responses to gonadotropin therapy, it has been possible to develop concepts concerning the mechanisms which operate during the normal menstrual cycle. It is shown that the ovarian requirement for FSH operates in a very narrow range, involving changes in concentration of only 10%; this range operates from a threshold level, through an intermediate level to a maximum level. After adequate stimulation, the follicle goes through a costing phase during which it is independent of further FSH stimulation and it acquires sensitivity to LH. Methods for determining optimum requirements for FSH and HCG for the induction of singleton pregnancies are presented. The relevance of the findings in providing hypotheses explaining some aspects of ovulatory and anovulatory cycles are discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 278588     DOI: 10.1111/j.1479-828x.1978.tb00011.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  37 in total

1.  A case report: successful pregnancy after controlled ovarian hyperstimulation by using short-acting gonadotropin releasing hormone agonist only.

Authors:  Fei Gong; Sufen Cai; Shunji Zhang; Changfu Lu; Ge Lin; Guangxiu Lu
Journal:  J Assist Reprod Genet       Date:  2012-02-09       Impact factor: 3.412

Review 2.  Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function.

Authors:  Livio Casarini; Elisa Pignatti; Manuela Simoni
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

3.  Preovulatory serum gonadotropin levels in hMG stimulated menstrual cycles in pregnant and nonpregnant patients.

Authors:  J F van Uem; A A Acosta; J E Garcia; Z Rosenwaks
Journal:  Arch Gynecol       Date:  1987

Review 4.  Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment.

Authors:  Ali Abbara; Sophie A Clarke; Waljit S Dhillo
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

Review 5.  Ovulation Induction for the General Gynecologist.

Authors:  Steven R Lindheim; Tanya L Glenn; Megan C Smith; Pascal Gagneux
Journal:  J Obstet Gynaecol India       Date:  2018-05-12

6.  Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: a prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol.

Authors:  J Balasch; F Fábregues; M Creus; R Casamitjana; B Puerto; J A Vanrell
Journal:  J Assist Reprod Genet       Date:  2000-11       Impact factor: 3.412

7.  The use of follicle-stimulating hormone for controlled ovarian hyperstimulation in in vitro fertilization.

Authors:  D Navot; Z Rosenwaks
Journal:  J In Vitro Fert Embryo Transf       Date:  1988-02

8.  The Relationship Between Progesterone, Sleep, and LH and FSH Secretory Dynamics in Early Postmenarchal Girls.

Authors:  Bob Z Sun; Tairmae Kangarloo; Judith M Adams; Patrick Sluss; Donald W Chandler; David T Zava; John A McGrath; David M Umbach; Natalie D Shaw
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

Review 9.  Approaches to improve the diagnosis and management of infertility.

Authors:  P Devroey; B C J M Fauser; K Diedrich
Journal:  Hum Reprod Update       Date:  2009-04-20       Impact factor: 15.610

10.  Current trends in the treatment of polycystic ovary syndrome with desire for children.

Authors:  Margalida E Sastre; Maria O Prat; Miguel Angel Checa; Ramon C Carreras
Journal:  Ther Clin Risk Manag       Date:  2009-05-20       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.